News
The companies said their long-term goal is to develop and offer more digital health tools "through a multi-partner ecosystem" as well as advocate for reimbursement options.
The funding will also go toward attracting leadership talent and accelerating product development, marketing and sales.
The digital mental health unicorn confirmed it received a grand jury subpoena from the U.S. Attorney's Office for the Eastern District of New York on the evening of May 4.
The clinical trial with Huntsville Heart Center is expected to be completed by October.
The clearance represents what could be the world's first regulatory approval of a DTx app for hypertension treatment.
Also: Butterfly Network reports a year-over-year revenue increase of more than 25%, with a $44.5 million net loss, and One Medical announces a significant jump in revenue.
The size of the healthcare industry is attractive to entrepreneurs, but the highly regulated field can be a challenge for startups.
Their first project will involve the use of AI contouring to cut time for planning radiation therapies.
Under the deal, MedRhythms would receive a $3 million upfront payment and could earn up to $117.5 million if certain milestones are met.
The round included a strategic investment from pharma giant Gilead Sciences to expand their partnership for decentralized and hybrid trials.